Prof. dr. Mateja Erdani Kreft and asist. Taja Železnik Ramuta from the Institute of Cell Biology prepared an antimicrobal agent from human amniotic membrane.
It works against several Gramm positive and Gramm negative bacteria, including some bacteria that are resistant against several antibiotics. Such bacteria can cause severe hospital infections. With the support of the Knowledge Transfer Office of the University of Ljubljana the researchers protected the procedure for the preparation of the amniotic membrane homogenate by international PCT patent (WO2020/157195, 06.08.2020), which is valid in all the countries that signed the Patent Cooperation Treaty.